Brachytherapy Systems

  • Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k) clearance for treatment of skin cancer. The Photoelectric Therapy System is a compact and ergonomic superficial X-ray therapy system operating in the 10kV to 80kV range intended...

  • For men with intermediate-risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects. The findings come from research presented at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO)...

  • In recent years, intraoperative radiation therapy (IORT) has been growing in acceptance in the U.S. as an alternative to traditional external beam radiation therapy (EBRT) for patients with early-stage breast cancer. For patients meeting appropriate selection criteria, the benefits are clear —...

  • Results from a randomized controlled trial comparing permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer showed brachytherapy patients were twice as likely to be cancer-free five years later.

  • Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance system. The technology uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures.

Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017

October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines...

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017

October 20, 2017 — Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug...

News | Brachytherapy Systems | October 05, 2017

October 5, 2017 — External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent...

International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017

October 4, 2017 — Findings from a new multicenter, international clinical trial confirm the effectiveness of...

Pelvic Radiation Confirmed as Standard of Care for High-Risk, Early-Stage Endometrial Cancer
News | Brachytherapy Systems, Women's Healthcare | September 28, 2017

September 28, 2017 — In a new phase III trial report, recurrence-free and overall survival rates for women with...

China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017

August 30, 2017 — iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from...

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017

August 3, 2017 — Researchers presented ...

Electronic Brachytherapy Comparable to Mohs Surgery in Early-Stage Non-Melanoma Skin Cancer Treatment
News | Brachytherapy Systems | July 20, 2017

July 20, 2017 — Rates of recurrence in early-stage non-melanoma skin cancer (NMSC) patients were virtually identical...

Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
News | Brachytherapy Systems, Women's Healthcare | May 01, 2017

May 1, 2017 — iCAD Inc. announced the first early-stage breast cancer patient was treated in Australia with...

New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017

April 20, 2017 — iCAD Inc. announced that updated clinical data on the use of...

iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference
News | Brachytherapy Systems | March 15, 2017

March 15, 2017 — iCAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with...

prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017

March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...

Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer
News | Brachytherapy Systems | January 16, 2017

January 16, 2017 — On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region...

iCAD, IORT boost, Xoft Axxent Electronic Brachytherapy System, intraoperative radiation therapy, whole breast radiation, early-stage breast cancer, SABCS 2016
News | Brachytherapy Systems | January 05, 2017

January 5, 2017 — iCAD Inc. announced that researchers presented updated data on the use of...

Samsung, Neurologica, BodyTom CT scanner, Willis-Knighton Health System, Louisiana, La., brachytherapy, radiation therapy, ASTRO 2016
News | Computed Tomography (CT) | October 27, 2016

October 27, 2016 — Samsung announced in September that the Willis-Knighton Cancer Center in Shreveport, La., added...

intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016

October 25, 2016 — For men with intermediate-risk...

Elekta, ASTRO 2016, HD Dynamic Radiosurgery, brachytherapy
News | Radiation Therapy | September 26, 2016

September 26, 2016 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston,...

balloon catheter, IORT

The Xoft Axxent Controller, balloon and mini X-ray source assembled to simulate use during IORT. 

Feature | Women's Health | June 01, 2016 | By Barbara Schwartzberg, M.D., FACS

In recent years, intraoperative radiation therapy (IORT) has been growing in acceptance in the U.S. as an...

Concure Oncology, Breast Microseed Treatment, one day, low-dose rate brachytherapy, LDR
Technology | Brachytherapy Systems, Women's Healthcare | May 12, 2016

May 12, 2016 — Concure Oncology/Breast Microseed Inc. announced the launch of its one-time, one-hour...

News | Brachytherapy Systems, Women's Healthcare | April 20, 2016

April 20, 2016 — Cianna Medical Inc. announced new clinical data evaluating the Savi Scout...

Overlay Init